Robin’s main interest is in the pathophysiology of functional GI diseases, particularly focusing on the role of infection and inflammation and alterations in serotonin metabolism in the irritable bowel syndrome. He has twice edited the British Society of Gastroenterology (BSG) Guidelines for the management of IBS and is a member of the Board of the Rome Foundation, an international group which produced the Rome III criteria for the classification of the functional GI diseases.
He was the founding Chairman of the Neurogastroenterology and Motility Section of the British Society of Gastroenterology (BSG)
He was a member of MRC EME Board 2010-2014 and National Institute for Health Research Senior Investigator. He is the author/co-author of more than 335 scientific reviews and original publications.